Citi analyst Yigal Nochomovitz raised ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst PT Change

Ultragenyx Pharma (RARE), GeneTx Report Investigational New Drug Application Active for GTX-102 in Patients with Angelman SyndromeJanuary 15, 2020 4:02 PM Ultragenyx Pharma (RARE), Kyowa Kirin Report Submission of Supplemental Biologics License Application to FDA for Crysvita (burosumab)January 13, 2020 8:18 AM